135 related articles for article (PubMed ID: 30343659)
1. Telementoring for hepatitis C treatment in correctional facilities.
Neuhaus M; Langbecker D; Caffery LJ; Taylor M; Garner L; Williams G; Smith AC; Macdonald GA
J Telemed Telecare; 2018 Dec; 24(10):690-696. PubMed ID: 30343659
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnel.
Lafferty L; Rance J; Dore GJ; Grebely J; Lloyd AR; Treloar C;
Int J Drug Policy; 2021 Dec; 98():103379. PubMed ID: 34311138
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C in Australian prisons: a national needs assessment.
Mina MM; Herawati L; Butler T; Lloyd A
Int J Prison Health; 2016; 12(1):3-16. PubMed ID: 26933988
[TBL] [Abstract][Full Text] [Related]
4. "You need a designated officer" - Recommendations from correctional and justice health personnel for scaling up hepatitis C treatment-as-prevention in the prison setting.
Lafferty L; Rance J; Byrne M; Milat A; Dore GJ; Grebely J; Lloyd AR; Treloar C;
Int J Drug Policy; 2022 Aug; 106():103746. PubMed ID: 35636069
[TBL] [Abstract][Full Text] [Related]
5. Patient and healthcare provider experiences of hepatitis C treatment with direct-acting antivirals in Rwanda: a qualitative exploration of barriers and facilitators.
Serumondo J; Penkunas MJ; Niyikora J; Ngwije A; Kiromera A; Musabeyezu E; Umutesi J; Umuraza S; Musengimana G; Nsanzimana S
BMC Public Health; 2020 Jun; 20(1):946. PubMed ID: 32546216
[TBL] [Abstract][Full Text] [Related]
6. General practitioner attitudes to prescribing hepatitis C antiviral therapy in a community setting.
Lambert SM; Page AN; Wittmann J; Hayllar JS; Ferndale CW; Bain TM; Macdonald GA
Aust J Prim Health; 2011; 17(3):282-7. PubMed ID: 21896265
[TBL] [Abstract][Full Text] [Related]
7. Considering treatment-as-prevention scale-up for Australian prisons: a qualitative sub-study of expert stakeholders from the Australian 'surveillance and treatment of prisoners with hepatitis C' project (SToP-C).
Rance J; Lafferty L; Treloar C;
Harm Reduct J; 2021 Apr; 18(1):46. PubMed ID: 33902595
[TBL] [Abstract][Full Text] [Related]
8. Use of telehealth to increase treatment access for prisoners with chronic hepatitis C.
Halder A; Li VG; Sebastian M; Nazareth S; Tuma R; Cheng W; Doyle A
Intern Med J; 2021 Aug; 51(8):1344-1347. PubMed ID: 34423535
[TBL] [Abstract][Full Text] [Related]
9. Social capital strategies to enhance hepatitis C treatment awareness and uptake among men in prison.
Lafferty L; Treloar C; Guthrie J; Chambers GM; Butler T
J Viral Hepat; 2017 Feb; 24(2):111-116. PubMed ID: 27778436
[TBL] [Abstract][Full Text] [Related]
10. Safety and effectiveness of a nurse-led outreach program for assessment and treatment of chronic hepatitis C in the custodial setting.
Lloyd AR; Clegg J; Lange J; Stevenson A; Post JJ; Lloyd D; Rudge G; Boonwaat L; Forrest G; Douglas J; Monkley D
Clin Infect Dis; 2013 Apr; 56(8):1078-84. PubMed ID: 23362288
[TBL] [Abstract][Full Text] [Related]
11. An Evaluation of Hepatitis C Virus Telehealth Services Serving Tribal Communities: Patterns of Usage, Evolving Needs, and Barriers.
Stephens D; Leston J; Terrault NA; Gailloux K; Mera J; Essex W; Reilley B
J Public Health Manag Pract; 2019; 25 Suppl 5, Tribal Epidemiology Centers: Advancing Public Health in Indian Country for Over 20 Years():S97-S100. PubMed ID: 31348196
[TBL] [Abstract][Full Text] [Related]
12. A Budget Impact Analysis of Newly Available Hepatitis C Therapeutics and the Financial Burden on a State Correctional System.
Nguyen JT; Rich JD; Brockmann BW; Vohr F; Spaulding A; Montague BT
J Urban Health; 2015 Aug; 92(4):635-49. PubMed ID: 25828149
[TBL] [Abstract][Full Text] [Related]
13. The role of social capital in facilitating hepatitis C treatment scale-up within a treatment-as-prevention trial in the male prison setting.
Lafferty L; Rance J; Dore GJ; Lloyd AR; Treloar C
Addiction; 2021 May; 116(5):1162-1171. PubMed ID: 33006784
[TBL] [Abstract][Full Text] [Related]
14. The contribution of telemedicine to hepatitis C elimination in a correctional facility.
Jiménez Galán G; Alia Alia C; Vegue González M; García Berriguete RMª; Fernández González F; Fernández Rodríguez CM; González Fernández M; Gutiérrez García ML; Losa JE; Velasco M; Moreno L; Hervás R; Delgado-Iribarren A; Palacios García-Cervigón G
Rev Esp Enferm Dig; 2019 Jul; 111(7):550-555. PubMed ID: 31215210
[TBL] [Abstract][Full Text] [Related]
15. Using telehealth to improve access to hepatitis C treatment in the direct-acting antiviral therapy era.
Schulz TR; Kanhutu K; Sasadeusz J; Watkinson S; Biggs BA
J Telemed Telecare; 2020 Apr; 26(3):180-185. PubMed ID: 30336724
[TBL] [Abstract][Full Text] [Related]
16. Economic modelling of telehealth substitution of face-to-face specialist outpatient consultations for Queensland correctional facilities.
Taylor M; Caffery LJ; Scuffham PA; Smith AC
Aust Health Rev; 2018 Sep; 42(5):522-528. PubMed ID: 29179811
[TBL] [Abstract][Full Text] [Related]
17. Universal opt-out screening for hepatitis C virus (HCV) within correctional facilities is an effective intervention to improve public health.
Morris MD; Brown B; Allen SA
Int J Prison Health; 2017 Sep; 13(3-4):192-199. PubMed ID: 28914118
[TBL] [Abstract][Full Text] [Related]
18. Personality disorders do not affect treatment outcomes for chronic HCV infection in Spanish prisoners: the Perseo study.
Marco A; Antón JJ; Trujols J; Saíz de la Hoya P; de Juan J; Faraco I; Caylà JA;
BMC Infect Dis; 2015 Aug; 15():355. PubMed ID: 26286450
[TBL] [Abstract][Full Text] [Related]
19. Aiming for elimination: Outcomes of a consultation pathway supporting regional general practitioners to prescribe direct-acting antiviral therapy for hepatitis C.
Wade AJ; McCormack A; Roder C; McDonald K; Davies M; Scott N; Wardrop M; Athan E; Hellard ME
J Viral Hepat; 2018 Sep; 25(9):1089-1098. PubMed ID: 29660212
[TBL] [Abstract][Full Text] [Related]
20. Enhancing assessment and treatment of hepatitis C in the custodial setting.
Post JJ; Arain A; Lloyd AR
Clin Infect Dis; 2013 Aug; 57 Suppl 2():S70-4. PubMed ID: 23884069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]